Group 1 - Cambrian's private placement price is set at 1195.02 yuan per share, with a total fundraising amount of 3.985 billion yuan [4] - Bee Assistant plans to raise no more than 984 million yuan for projects including cloud terminal computing power center and IoT terminal upgrades [5] - Kexing Pharmaceutical is planning to issue H-shares and list on the Hong Kong Stock Exchange [6] - Three squirrels have received approval from the China Securities Regulatory Commission for H-share issuance, with plans to issue up to 81.5483 million shares [7] - Ruiming Technology has submitted an application for H-share issuance to the Hong Kong Stock Exchange [8] Group 2 - Binhua Co. plans to invest 1.421 billion yuan in an integrated project for wind, solar, and energy storage [9] - Sains plans to invest no more than 300 million yuan in the expansion of its selection agent project [10] Group 3 - Hunan YN reports no significant changes in its internal and external operating environment [11] - Electric Power Investment has had its major asset replacement review suspended by the Shenzhen Stock Exchange due to expired financial documents [12] - Guanzhong Ecological is in the planning stage for acquiring a 51% stake in Hangzhou Actuary [13][14] Group 4 - Aima Technology's subsidiary is transferring production capacity and ceasing operations due to strategic adjustments [17] - Fosun Pharma's subsidiary has received approval for clinical trials of a new drug [18] - SAIC Group's subsidiary plans to invest 666 million yuan in the restructuring of SAIC Hongyan [19] Group 5 - Hanwei Technology plans to sell 65% of Hanwei Zhiyuan for approximately 440 million yuan [20] - Xingtong Co. has been awarded new capacity for coastal inter-provincial bulk liquid hazardous goods transportation [21][22] Group 6 - EVE Battery Investment received a cash dividend of 375 million HKD from its associate company [23] - Shanmei International's chairman has resigned due to work changes [24] - Weiye Co.'s chairman has resigned for personal reasons [25] Group 7 - Jiao Da Sino's chairman has been placed under detention [26] - Duorui Pharmaceutical is planning a change in control, leading to a stock suspension [27][28] - *ST Zhengping's stock has been suspended for investigation due to abnormal price fluctuations [29] Group 8 - Zhenray Technology's chairman has had detention measures lifted [30] - Shiming Technology's chairman has had detention measures changed to a warning [31] - Nanxin Pharmaceutical is under investigation by the CSRC for suspected violations in annual report disclosures [32] Group 9 - Daqian Ecology's shareholder plans to reduce holdings by up to 3% [33] - Rundar Medical's shareholders plan to reduce holdings by up to 2.99% [34][35] - Saili Medical's shareholder plans to reduce holdings by up to 2% [36] Group 10 - Huaxin Environmental plans to repurchase shares for 40 to 80 million yuan [37] - Tianyong Intelligent has been awarded a contract worth 58.8 million yuan for an engine assembly line project [38] - Zhongwu Drone has signed a significant contract worth 615 million yuan for drone systems [39]

Core Points - Zhenlei Technology (688270) announced that the detention measures against its actual controller and chairman, Yu Faxin, have been lifted by the Huangshi Municipal Supervisory Committee, allowing him to resume his duties as chairman [1] - Prior to this, on September 22, Zhenlei Technology disclosed that Yu Faxin was under detention measures and was temporarily unable to fulfill his responsibilities as a director [1]

Group 1 - Cambrian's private placement price is set at 1195.02 yuan per share, with a total fundraising amount of 3.985 billion yuan [2] - Bee Assistant plans to raise up to 984 million yuan for projects including cloud terminal computing power center and IoT terminal upgrades [3] - Kexing Pharmaceutical is planning to issue H-shares and list on the Hong Kong Stock Exchange [4] Group 2 - Three squirrels received approval from the China Securities Regulatory Commission for H-share issuance, planning to issue up to 81.5483 million shares [5] - Ruiming Technology has submitted an application for H-share issuance to the Hong Kong Stock Exchange [6] - Binhua Co. plans to invest 1.421 billion yuan in an integrated project for wind and solar energy [7] Group 3 - Sainz's subsidiary plans to invest up to 300 million yuan in the expansion of selection and extraction agents [8] - Hunan YN reported no significant changes in its internal and external operating environment [9] - Electric Power Investment plans to restructure assets and has received a notice from the Shenzhen Stock Exchange to suspend review [10] Group 4 - Guanzhong Ecology is in the planning stage to acquire 51% of Hangzhou Actuary [11] - Aima Technology announced the transfer and suspension of production capacity at its subsidiary in Guangdong [12] - Fosun Pharma's subsidiary received approval for clinical trials of a new drug [13] Group 5 - EVE Battery Investment received a cash dividend of 375 million HKD from its indirect associate, Simoer International [14] - Shanmei International announced a change in its board leadership due to personnel changes [15] - Weiye Co. announced the resignation of its chairman for personal reasons [16] Group 6 - Jiaoda Sinuo's chairman is under detention, and the company has appointed a new acting chairman [17] - Duorui Pharmaceutical is planning a change in control, leading to a stock suspension [18] - ST Zhengping's stock price has seen an abnormal increase, leading to a suspension for investigation [19] Group 7 - Daqian Ecology's shareholder plans to reduce its stake by up to 3% [20] - Rundat Medical's shareholders plan to collectively reduce their stake by up to 2.99% [21] - Seli Medical's shareholder plans to reduce its stake by up to 2% [22] Group 8 - Tianyong Intelligent has been awarded a contract worth 58.8 million yuan for an engine assembly line project [23] - Zhongwu Drone signed a significant contract worth 615 million yuan for drone systems [24]

Core Viewpoint - Zhenray Technology announced a share buyback plan, indicating confidence in its stock value and commitment to returning capital to shareholders [1] Summary by Categories Company Actions - As of September 30, 2025, Zhenray Technology has repurchased a total of 393,991 shares through a dedicated securities account via centralized bidding, representing 0.1841% of the company's total share capital [1]

一、回购股份的基本情况 证券代码：688270 证券简称：臻镭科技 公告编号：2025-044 浙江臻镭科技股份有限公司 关于股份回购进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： | 回购方案首次披露日 | 2024/10/25 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 回购方案实施期限 | 2024 年 10 | 10 | 月 | 25 | 日~2025 | 年 | 月 | 24 | 日 | | 预计回购金额 | 2,000万元~4,000万元 | | | | | | | | | | 回购用途 | □减少注册资本 √用于员工持股计划或股权激励 | | | | | | | | | | | □用于转换公司可转债 | | | | | | | | | | | □为维护公司价值及股东权益 | | | | | | | | | | 累计已回购股数 | 393,991股 | | | | | | ...

Group 1 - The company, Zhenlei Technology, announced on September 30 that it has repurchased approximately 390,000 shares, accounting for 0.1841% of its total share capital, through a special securities account via centralized bidding [1] - The highest transaction price for the repurchased shares was 70.93 yuan per share, while the lowest was 31.6 yuan per share [1] - The total amount spent on the share repurchase was approximately 20.01 million yuan [1]

特此公告。 浙江臻镭科技股份有限公司（以下简称"公司"）于 2025 年 9 月 22 日披露 了《关于公司重大事项的公告》（公告编号：2025-043），公司实际控制人、董 事长郁发新先生被黄石市监察委员会实施留置措施，暂不能履行董事相关职责。 公司于近日从郁发新先生家属处获悉，黄石市监察委员会已解除对郁发新先 生的留置措施。目前郁发新先生能够正常履行公司董事长职责，公司董事张兵先 生不再代为履行董事长的相关职责。 公司指定的信息披露媒体为上海证券报（www.cnstock.com）、证券时报 （www.stcn.com）、证券日报（www.zqrb.cn）、经济参考网（www.jjckb.cn）及 上海证券交易所网站（www.sse.com.cn）,公司发布的信息均以在上述指定媒体刊 登的信息为准。敬请广大投资者理性投资，注意投资风险。 证券代码：688270 证券简称：臻镭科技 公告编号：2025-045 浙江臻镭科技股份有限公司 关于公司实际控制人、董事长解除留置的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责 ...

格隆汇9月30日丨臻镭科技(688270.SH)公布，截至2025年9月30日收盘，公司通过股份回购专用证券账 户以集中竞价交易方式累计回购公司股份393,991股，占公司目前总股本的0.1841%，最高成交价为 70.93元/股，最低成交价为31.6元/股，成交总金额为2,000.098万元（不含印花税、交易佣金等交易费 用）。 ...

格隆汇9月30日丨臻镭科技(688270.SH)公布，公司于近日从郁发新先生家属处获悉，黄石市监察委员会 已解除对郁发新先生的留置措施。目前郁发新先生能够正常履行公司董事长职责，公司董事张兵先生不 再代为履行董事长的相关职责。 ...

智通财经APP讯，臻镭科技(688270.SH)发布公告，此前，公司实际控制人、董事长郁发新先生被黄石 市监察委员会实施留置措施，暂不能履行董事相关职责。公司于近日从郁发新先生家属处获悉，黄石市 监察委员会已解除对郁发新先生的留置措施。目前郁发新先生能够正常履行公司董事长职责，公司董事 张兵先生不再代为履行董事长的相关职责。 ...